New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived <i>Micromonospora</i> Strains

Antimicrobial resistance can be considered a hidden global pandemic and research must be reinforced for the discovery of new antibiotics. The spirotetronate class of polyketides, with more than 100 bioactive compounds described to date, has recently grown with the discovery of phocoenamicins, compou...

Full description

Bibliographic Details
Main Authors: Maria Kokkini, Daniel Oves-Costales, Pilar Sánchez, Ángeles Melguizo, Thomas A. Mackenzie, Mercedes Pérez-Bonilla, Jesús Martín, Arianna Giusti, Peter de Witte, Francisca Vicente, Olga Genilloud, Fernando Reyes
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Marine Drugs
Subjects:
Online Access:https://www.mdpi.com/1660-3397/21/8/443
_version_ 1797584014746320896
author Maria Kokkini
Daniel Oves-Costales
Pilar Sánchez
Ángeles Melguizo
Thomas A. Mackenzie
Mercedes Pérez-Bonilla
Jesús Martín
Arianna Giusti
Peter de Witte
Francisca Vicente
Olga Genilloud
Fernando Reyes
author_facet Maria Kokkini
Daniel Oves-Costales
Pilar Sánchez
Ángeles Melguizo
Thomas A. Mackenzie
Mercedes Pérez-Bonilla
Jesús Martín
Arianna Giusti
Peter de Witte
Francisca Vicente
Olga Genilloud
Fernando Reyes
author_sort Maria Kokkini
collection DOAJ
description Antimicrobial resistance can be considered a hidden global pandemic and research must be reinforced for the discovery of new antibiotics. The spirotetronate class of polyketides, with more than 100 bioactive compounds described to date, has recently grown with the discovery of phocoenamicins, compounds displaying different antibiotic activities. Three marine <i>Micromonospora</i> strains (CA-214671, CA-214658 and CA-218877), identified as phocoenamicins producers, were chosen to scale up their production and LC/HRMS analyses proved that EtOAc extracts from their culture broths produce several structurally related compounds not disclosed before. Herein, we report the production, isolation and structural elucidation of two new phocoenamicins, phocoenamicins D and E (<b>1</b>–<b>2</b>), along with the known phocoenamicin, phocoenamicins B and C (<b>3</b>–<b>5</b>), as well as maklamicin (<b>7</b>) and maklamicin B (<b>6</b>), the latter being reported for the first time as a natural product. All the isolated compounds were tested against various human pathogens and revealed diverse strong to negligible activity against methicillin-resistant <i>Staphylococcus aureus</i>, <i>Mycobacterium tuberculosis</i> H37Ra, <i>Enterococcus faecium</i> and <i>Enterococcus faecalis</i>. Their cell viability was also evaluated against the human liver adenocarcinoma cell line (Hep G2), demonstrating weak or no cytotoxicity. Lastly, the safety of the major compounds obtained, phocoenamicin (<b>3</b>), phocoenamicin B (<b>4</b>) and maklamicin (<b>7</b>), was tested against zebrafish eleuthero embryos and all of them displayed no toxicity up to a concentration of 25 μM.
first_indexed 2024-03-10T23:46:15Z
format Article
id doaj.art-25ec2d2a470f457cb2fcf2e150e17006
institution Directory Open Access Journal
issn 1660-3397
language English
last_indexed 2024-03-10T23:46:15Z
publishDate 2023-08-01
publisher MDPI AG
record_format Article
series Marine Drugs
spelling doaj.art-25ec2d2a470f457cb2fcf2e150e170062023-11-19T01:58:08ZengMDPI AGMarine Drugs1660-33972023-08-0121844310.3390/md21080443New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived <i>Micromonospora</i> StrainsMaria Kokkini0Daniel Oves-Costales1Pilar Sánchez2Ángeles Melguizo3Thomas A. Mackenzie4Mercedes Pérez-Bonilla5Jesús Martín6Arianna Giusti7Peter de Witte8Francisca Vicente9Olga Genilloud10Fernando Reyes11Fundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, Armilla, 18016 Granada, SpainFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, Armilla, 18016 Granada, SpainFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, Armilla, 18016 Granada, SpainFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, Armilla, 18016 Granada, SpainFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, Armilla, 18016 Granada, SpainFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, Armilla, 18016 Granada, SpainFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, Armilla, 18016 Granada, SpainLaboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, O & N II Herestraat 49-box 824, 3000 Leuven, BelgiumLaboratory for Molecular Biodiscovery, Department of Pharmaceutical and Pharmacological Sciences, University of Leuven, O & N II Herestraat 49-box 824, 3000 Leuven, BelgiumFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, Armilla, 18016 Granada, SpainFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, Armilla, 18016 Granada, SpainFundación MEDINA, Centro de Excelencia en Investigación de Medicamentos Innovadores en Andalucía, Parque Tecnológico Ciencias de la Salud, Avda. del Conocimiento 34, Armilla, 18016 Granada, SpainAntimicrobial resistance can be considered a hidden global pandemic and research must be reinforced for the discovery of new antibiotics. The spirotetronate class of polyketides, with more than 100 bioactive compounds described to date, has recently grown with the discovery of phocoenamicins, compounds displaying different antibiotic activities. Three marine <i>Micromonospora</i> strains (CA-214671, CA-214658 and CA-218877), identified as phocoenamicins producers, were chosen to scale up their production and LC/HRMS analyses proved that EtOAc extracts from their culture broths produce several structurally related compounds not disclosed before. Herein, we report the production, isolation and structural elucidation of two new phocoenamicins, phocoenamicins D and E (<b>1</b>–<b>2</b>), along with the known phocoenamicin, phocoenamicins B and C (<b>3</b>–<b>5</b>), as well as maklamicin (<b>7</b>) and maklamicin B (<b>6</b>), the latter being reported for the first time as a natural product. All the isolated compounds were tested against various human pathogens and revealed diverse strong to negligible activity against methicillin-resistant <i>Staphylococcus aureus</i>, <i>Mycobacterium tuberculosis</i> H37Ra, <i>Enterococcus faecium</i> and <i>Enterococcus faecalis</i>. Their cell viability was also evaluated against the human liver adenocarcinoma cell line (Hep G2), demonstrating weak or no cytotoxicity. Lastly, the safety of the major compounds obtained, phocoenamicin (<b>3</b>), phocoenamicin B (<b>4</b>) and maklamicin (<b>7</b>), was tested against zebrafish eleuthero embryos and all of them displayed no toxicity up to a concentration of 25 μM.https://www.mdpi.com/1660-3397/21/8/443antimicrobial resistancedrug discoverynatural productsmarine actinomycetespolyketidesspirotetronates
spellingShingle Maria Kokkini
Daniel Oves-Costales
Pilar Sánchez
Ángeles Melguizo
Thomas A. Mackenzie
Mercedes Pérez-Bonilla
Jesús Martín
Arianna Giusti
Peter de Witte
Francisca Vicente
Olga Genilloud
Fernando Reyes
New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived <i>Micromonospora</i> Strains
Marine Drugs
antimicrobial resistance
drug discovery
natural products
marine actinomycetes
polyketides
spirotetronates
title New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived <i>Micromonospora</i> Strains
title_full New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived <i>Micromonospora</i> Strains
title_fullStr New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived <i>Micromonospora</i> Strains
title_full_unstemmed New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived <i>Micromonospora</i> Strains
title_short New Phocoenamicin and Maklamicin Analogues from Cultures of Three Marine-Derived <i>Micromonospora</i> Strains
title_sort new phocoenamicin and maklamicin analogues from cultures of three marine derived i micromonospora i strains
topic antimicrobial resistance
drug discovery
natural products
marine actinomycetes
polyketides
spirotetronates
url https://www.mdpi.com/1660-3397/21/8/443
work_keys_str_mv AT mariakokkini newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains
AT danielovescostales newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains
AT pilarsanchez newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains
AT angelesmelguizo newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains
AT thomasamackenzie newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains
AT mercedesperezbonilla newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains
AT jesusmartin newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains
AT ariannagiusti newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains
AT peterdewitte newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains
AT franciscavicente newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains
AT olgagenilloud newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains
AT fernandoreyes newphocoenamicinandmaklamicinanaloguesfromculturesofthreemarinederivedimicromonosporaistrains